Disopyramide
Contents
Description
Disopyramide is a Class IA antiarrhythmic agent with negative inotropic properties that has been used off-label for decades in the management of obstructive hypertrophic cardiomyopathy. It reduces left ventricular outflow tract obstruction by decreasing myocardial contractility. While not specifically approved for hypertrophic cardiomyopathy, it remains a treatment option when other therapies are not suitable.
Indications & Therapeutic Use
ventricular arrhythmias, off-label use in obstructive hypertrophic cardiomyopathy
Linked Diseases:
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Disopyramide — GNH India
35 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | disopyramide |
| Brands | 1 brand available |
| Active Ingredient | disopyramide phosphate |
| Drug Class | ventricular arrhythmias |
| Manufacturer | Pfizer |
| Dosage Forms | oral capsule, 100mg, 150mg; extended-release capsule, 100mg, 150mg |
| Medical Code | C01BA03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 7 countries |